tiprankstipranks
Trending News
More News >
Kalaris Therapeutics (KLRS)
NASDAQ:KLRS
US Market
Advertisement

Kalaris Therapeutics (KLRS) Similar Stocks

Compare
351 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Kalaris Therapeutics
$4.62
$78.00M
-73.72%
3 Buy
1 Hold
0 Sell
Strong Buy
Coherus Biosciences
$1.29
$152.26M
5.55
4.03%
3 Buy
1 Hold
0 Sell
Strong Buy
Nektar Therapeutics
$40.18
$684.29M
139.17%
6 Buy
1 Hold
1 Sell
Moderate Buy
Cellectis SA
$2.68
$190.14M
19.64%
0 Buy
1 Hold
0 Sell
Hold
Seres Therapeutics
$19.36
$169.49M
1.47%
2 Buy
0 Hold
0 Sell
Moderate Buy
Kodiak Sciences
$10.52
$451.63M
355.41%
0 Buy
2 Hold
1 Sell
Moderate Sell

Performance Comparison

Ticker
Company Name
Price
Change
% Change
KLRS
Kalaris Therapeutics
4.62
-12.48
-72.98%
CHRS
Coherus Biosciences
1.29
-0.02
-1.53%
NKTR
Nektar Therapeutics
40.18
22.48
127.01%
CLLS
Cellectis SA
2.68
0.42
18.58%
MCRB
Seres Therapeutics
19.36
-1.24
-6.02%
KOD
Kodiak Sciences
10.52
8.14
342.02%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis